Rosetta Genomics' Q3 Loss Rises 13 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Rosetta Genomics today reported that its third-quarter 2009 net loss increased 13 percent as the firm rolled out its microRNA-based tests, which it expects will provide a stream of revenues during 2010.

The Rehovot, Israel-based firm did not report any revenues for the third quarters of 2009 or 2008. Its marketing partners recently introduced the firm's first three tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.